OTCMKTS:SGIOY Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Stock Price, News & Analysis $8.80 -0.12 (-1.35%) As of 10/2/2026 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsInsider TradesNews and TrendsSEC FilingsShort Interest About Shionogi & Co., Ltd. Unsponsored ADR Stock (OTCMKTS:SGIOY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SGIOY alerts:Sign Up Key Stats Today's Range$8.61▼$8.9050-Day Range$8.69▼$9.5652-Week Range$7.65▼$12.00Volume72,318 shsAverage Volume190,451 shsMarket Capitalization$14.98 billionP/E Ratio8.80Dividend Yield1.59%Price TargetN/AConsensus RatingBuy Company Overview Shionogi & Co., Ltd. is a Japan-based research-driven pharmaceutical company headquartered in Osaka. Founded in 1878, the company discovers, develops, manufactures and markets prescription medicines, with a focus on infectious diseases, central nervous system disorders and other areas of unmet medical need. Shionogi’s portfolio includes Xofluza (baloxavir marboxil), an antiviral treatment for influenza, and F. (fostemsavir), an HIV treatment marketed in certain regions. The company also develops medicines for conditions including pain, psychiatric disorders and other diseases, while pursuing research in areas such as antimicrobial resistance and novel anti-infective therapies. Shionogi primarily serves the Japanese market and has expanded its international presence through subsidiaries, licensing arrangements and commercial partnerships in North America, Europe and other regions. The company conducts research and development, manufacturing and commercialization activities through its own operations and collaborations with other pharmaceutical organizations.AI Generated. May Contain Errors. Read More Shionogi & Co., Ltd. Unsponsored ADR Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreSGIOY MarketRank™: Shionogi & Co., Ltd. Unsponsored ADR scored higher than 44% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingBuy Consensus RatingShionogi & Co., Ltd. Unsponsored ADR has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageShionogi & Co., Ltd. Unsponsored ADR has only been the subject of 1 research reports in the past 90 days.Read more about Shionogi & Co., Ltd. Unsponsored ADR's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth-3.66% Earnings GrowthEarnings for Shionogi & Co., Ltd. Unsponsored ADR are expected to decrease by -3.66% in the coming year, from $0.82 to $0.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shionogi & Co., Ltd. Unsponsored ADR is 8.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.66.Price to Earnings Ratio vs. SectorThe P/E ratio of Shionogi & Co., Ltd. Unsponsored ADR is 8.80, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.67.Price to Earnings Growth RatioShionogi & Co., Ltd. Unsponsored ADR has a PEG Ratio of 3.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShionogi & Co., Ltd. Unsponsored ADR has a P/B Ratio of 1.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Shionogi & Co., Ltd. Unsponsored ADR's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.08% of the float of Shionogi & Co., Ltd. Unsponsored ADR has been sold short.Short Interest Ratio / Days to CoverShionogi & Co., Ltd. Unsponsored ADR has a short interest ratio ("days to cover") of 2.21, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shionogi & Co., Ltd. Unsponsored ADR has recently increased by 3,691.12%, indicating that investor sentiment is decreasing significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldShionogi & Co., Ltd. Unsponsored ADR pays a meaningful dividend of 1.59%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthShionogi & Co., Ltd. Unsponsored ADR does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Shionogi & Co., Ltd. Unsponsored ADR is 14.00%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Shionogi & Co., Ltd. Unsponsored ADR will have a dividend payout ratio of 17.72% next year. This indicates that Shionogi & Co., Ltd. Unsponsored ADR will be able to sustain or increase its dividend.Read more about Shionogi & Co., Ltd. Unsponsored ADR's dividend. News and Social Media3.1 / 5News SentimentN/A News SentimentShionogi & Co., Ltd. Unsponsored ADR has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Shionogi & Co., Ltd. Unsponsored ADR this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Shionogi & Co., Ltd. Unsponsored ADR insiders have not sold or bought any company stock.Percentage Held by Institutions1.92% of the stock of Shionogi & Co., Ltd. Unsponsored ADR is held by institutions.Read more about Shionogi & Co., Ltd. Unsponsored ADR's insider trading history. Receive SGIOY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shionogi & Co., Ltd. Unsponsored ADR and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SGIOY Stock News HeadlinesShionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Stock Short Interest Rises 3,691.1%September 26, 2026 | americanbankingnews.comAll You Need to Know About Shionogi & Co. (SGIOY) Rating Upgrade to BuyFebruary 4, 2026 | msn.comMy biggest prediction yet?!James Altucher once called Facebook's rise to a hundred-billion-dollar valuation and Apple's run to a trillion while experts laughed. Now he is making what he calls his biggest prediction yet. It centers on new drone footage from one of Elon Musk's expanding production facilities, tied to a product Musk reportedly calls an infinite money glitch, with production possibly starting in days. Altucher cites Dallas Fed data suggesting the opportunity could approach 2 quadrillion dollars by 2040.October 4 at 1:00 AM | Paradigm Press (Ad)Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exitsJanuary 20, 2026 | reuters.comYomiuri: Nobel Prize Winner, Shionogi Jointly Developing New Cancer DrugNovember 15, 2025 | marketwatch.comShionogi Weighs Making Antibiotics in US Amid Rising TariffsAugust 19, 2025 | bloomberg.comSGIOY | Shionogi & Co. Ltd. ADR Annual Balance Sheet - WSJJuly 15, 2025 | wsj.comShionogi’s Naldemedine Gains Approval in China for Opioid-Induced ConstipationMay 29, 2025 | tipranks.comSee More Headlines SGIOY Stock Analysis - Frequently Asked Questions How have SGIOY shares performed this year? Shionogi & Co., Ltd. Unsponsored ADR's stock was trading at $8.98 at the beginning of the year. Since then, SGIOY stock has decreased by 2.0% and is now trading at $8.80. How were Shionogi & Co., Ltd. Unsponsored ADR's earnings last quarter? Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) released its quarterly earnings results on Monday, August, 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.18. The company earned $1.04 billion during the quarter, compared to analysts' expectations of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a trailing twelve-month return on equity of 16.13%. How do I buy shares of Shionogi & Co., Ltd. Unsponsored ADR? Shares of SGIOY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/03/2026Today10/04/2026Next Earnings (Estimated)10/26/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:SGIOY CIK1281721 Webshionogi.com Phone(166) 202-2161FaxN/AEmployees6,223Year Founded1878Profitability EPS (Trailing Twelve Months)$1.00 Trailing P/E Ratio8.80 Forward P/E Ratio10.73 P/E Growth3.16Net Income$1.35 billion Net Margins46.67% Pretax Margin47.81% Return on Equity16.13% Return on Assets12.09% Debt Debt-to-Equity Ratio0.01 Current Ratio1.14 Quick Ratio1.00 Sales & Book Value Annual Sales$3.32 billion Price / Sales4.51 Cash Flow$0.91 per share Price / Cash Flow9.72 Book Value$6.54 per share Price / Book1.35Miscellaneous Outstanding Shares1,701,950,000Free FloatN/AMarket Cap$14.98 billion OptionableNot Optionable Beta0.08 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:SGIOY) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredMajor Buy Alert Issued for October 31stKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredFree Stock: Economist calls it “the world’s most important machine.”Nvidia's most expensive chip component isn't made by Nvidia. Jeff Brown, former semiconductor executive, says ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shionogi & Co., Ltd. Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Shionogi & Co., Ltd. Unsponsored ADR With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGIOY Stock Alerts